Your session is about to expire
← Back to Search
Cannabis for Alcoholism
Study Summary
This trial will test the effects of THC- and CBD-dominant strains of cannabis on alcohol consumption.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have smoked cannabis within the last two months.I am in good health and weigh less than 250 lbs.I am between 21 and 50 years old.I am in good health and weigh under 250 lbs.You have consumed a lot of alcohol in the last two months.
- Group 1: Placebo
- Group 2: THC-dominant cannabis dose
- Group 3: CBD-dominant cannabis dose
- Group 4: Alcohol priming dose
- Group 5: Alcohol placebo dose
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available positions for candidates in this clinical trial?
"The clinical trial is not recruiting patients right now but was last updated on May 20th, 2022. There are other 504 trials that are open for recruitment."
For which type of patient is this research appropriate?
"Eligible participants for this trial must be 21-50 years old, speak English, have smoked cannabis in the past 2 months, and have been heavy drinkers during that same time period. Candidates also cannot weigh more than 250lbs and must pass a breathalyzer test at each visit."
Could you please explain the risks of THC-rich cannabis for patients?
"There is some data backing the safety of THC-dominant cannabis, but as this is only a Phase 2 trial, meaning that there is no evidence yet of efficacy, it receives a score of 2."
Are octogenarians being sought for this trial?
"From the eligibility criteria, we can see that this study is for people aged 21-50. There are 50 studies involving patients under 18 and 309 with senior citizens."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger